After Hours
$
24.20
Change
0.00 0.00%
Volume
Volume 10,867
Mar 29, 2017, 6:51 p.m.
Quotes are delayed by 20 min
Previous close
$ 23.93
$ 24.20
Change
+0.27 +1.13%
Day low
Day high
$23.91
$24.88
52 week low
52 week high
$11.41
$24.88
Market cap
$3.68B
Average volume
1.93M
P/E ratio
N/A
Rev. per Employee
$353,496
EPS
-1.10
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on NKTR
-
Nektar Therapeutics' stock surges 16% premarket after positive pain treatment trial results
- Tomi Kilgore
-
The best (and worst) small-cap stocks since Donald Trump’s election
- Philip van Doorn
-
How you can bottom-feed for stocks left behind in the Trump rally
- Philip van Doorn
-
These small-cap stocks are expected to rise at least 31% in 2017
- Philip van Doorn
-
U.S. benchmarks extend uptrend on strong jobs report
- Michael Ashbaugh
-
AstraZeneca's NDA for Naloxegol accepted
- MarketWatch.com
-
Nike shares swoosh higher after earnings
- Wallace Witkowski
-
Nektar shares drop 25% after study misses endpoint
- Wallace Witkowski
-
FDA grants fast-track status for Nektar drug
- MarketWatch.com
-
S&P 500 clears trendline resistance
- Michael Ashbaugh
-
- Michael Ashbaugh
-
Wednesday’s biggest gaining & declining stocks
- Kate Gibson
-
Nektar sells royalties for two drugs
- MarketWatch.com
- Loading more headlines...
Where does this data come from?
Analyst Estimates »
A data point based on hundreds of brokers buy, sell and hold rating.
Sentiment on NKTR
Analyst Ratings
-
- Benzinga.com
-
Brean Weighs In On Nektar ONZEALD Deal
- Benzinga.com
Other News on NKTR
-
Could Nektar Therapeutics Be Worth More?
- Motley Fool
-
- GuruFocus.com
-
- Seeking Alpha
-
Stocks Weak Amid Fed Hawkishness on Rate Hikes
- InvestorPlace.com
-
Biotech Hits 11-Year High On Potential To Dethrone Oxycodone
- Investors Business Daily
-
Nektar Pharma Opioid Drug Shows Promise In Phase 3
- Investopedia.com
-
Why Nektar Therapeutics Inc. Is Rising Today
- Motley Fool
-
- 247WallSt.com
-
Premarket Gainers as of 9:05 am
- Seeking Alpha
-
Is Now the Time to Buy Into These 5 Biotech ETFs?
- InvestorPlace.com
- Loading more headlines...
Press Releases on NKTR
-
Nektar Therapeutics Partnering Deals and Alliances 2010 to 2017
- PR Newswire - PRF
-
Nektar Therapeutics Reports Fourth Quarter and Year-End 2016 Financial Results
- PR Newswire - PRF
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com
| Avg. APR | Last Week | 6 Months | |
|---|---|---|---|
| Low Interest | 12.47% | 12.44% | 11.98% |
| Business | 13.49% | 13.49% | 13.12% |
| Student | 13.79% | 13.73% | 13.42% |
| Balance Transfer | 14.89% | 14.86% | 14.39% |
| Airline | 15.62% | 15.59% | 15.13% |
| Cash Back | 15.66% | 15.63% | 15.33% |
| Reward | 15.70% | 15.67% | 15.30% |
| Instant Approval | 18.11% | 18.11% | 18.04% |
| Bad Credit | 23.17% | 23.04% | 22.86% |




